Metoprololtartraat Retard Cf

Metoprolol Tartrate, the active ingredient in Metoprololtartraat Retard Cf, is a beta blocker presented as an oral tablet for oral use. It is employed to lower high blood pressure, relieve chest pain from angina, and improve outcomes in heart failure and after myocardial infarction in adult patients.

GNH USA supplies Metoprololtartraat Retard Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Metoprolol Tartrate is a selective β1‑adrenergic blocker used in cardiovascular disease management.

- Hypertension: lowers systemic blood pressure by reducing cardiac output and inhibiting renin release. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Post‑myocardial infarction: reduces risk of recurrent infarction and improves survival. - Chronic heart failure: improves left‑ventricular function and reduces hospitalisation rates.

Metoprolol Tartrate may cause a range of adverse reactions.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea or abdominal discomfort. - Sleep disturbances: insomnia or vivid dreams.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to fainting or shock. - Bronchospasm in patients with reactive airway disease. - Allergic reactions such as rash, swelling, or anaphylaxis. - Worsening heart failure symptoms.

When prescribing Metoprolol Tartrate, clinicians should consider several safety measures.

- Dose adjustment in renal impairment: reduce dose or extend interval in patients with reduced kidney function. - Caution in asthma or COPD: β1‑selectivity may not fully prevent bronchoconstriction. - Monitor heart rate and blood pressure: ensure values remain within therapeutic range. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia or hypertension. - Pregnancy and lactation: consult a physician; benefits must outweigh potential risks. - Store below 25°C: keep in the original pack, protect from moisture.

Metoprolol Tartrate can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Calcium channel blockers (verapamil, diltiazem): combined use may cause severe bradycardia or AV block. - Other antihypertensives (ACE inhibitors, diuretics): additive blood‑pressure lowering effect. - Insulin or oral hypoglycemics: beta‑blockade may mask hypoglycaemia symptoms.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce the antihypertensive efficacy of metoprolol. - Clonidine: abrupt withdrawal after concurrent use can precipitate rebound hypertension. - Lithium: beta‑blockade can increase lithium serum concentrations, requiring level monitoring.